USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
Environmental Metrology Corporation
Address:
6595 North Oracle Road
Suite 153B
Tucson, AZ 85704-
Phone:
N/A
URL:
N/A
EIN:
999999999
DUNS:
999999999
Number of Employees:
3
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $893,192.00 5

Award List:

TAS::75 0849::TAS SYSTEMS FOR AUTOMATED STORAGE, ANALYSIS, AND REPORTING OF OBJECTIVE BEHAVIORAL EXPOSURES

Award Year / Program / Phase:
2011 / SBIR / Phase I
Award Amount:
$200,000.00
Agency:
HHS
Principal Investigator:
Fahd Albinali – 617-945-7572
Abstract:
The Contractor will develop an open-source software service that makes it extremely easy for a researcher to gather and analyze high-resolution activity and accelerometer data.

TAS::75 0849::TAS SYSTEMS FOR AUTOMATED STORAGE, ANALYSIS, AND REPORTING OF OBJECTIVE BEHAVIORAL EXPOSURES

Award Year / Program / Phase:
2011 / SBIR / Phase I
Award Amount:
$199,993.00
Agency:
HHS
Principal Investigator:
Duane Jung – 704-759-6540
Abstract:
The Contractor will collect software and data analysis requirements during two sets of workshops with their domain expert collaborators. The first step in the project will be to define an initial high level design across all major software subsystems. Thishigh level design will be in power point… More

SBIR TOPIC 283 PHASE I - DEVELOPMENT OF A MOLECULAR DIAGNOSTIC ASSAY TO DETECT BASAL-LIKE BREAST CANCER

Award Year / Program / Phase:
2011 / SBIR / Phase I
Award Amount:
$149,622.00
Agency:
HHS
Principal Investigator:
Roberto Fagnani – 908-625-5169
Abstract:
A molecular diagnostic test based on immunohistochemical detection of a characteristic protein biomarker will be developed to diagnose basal-like breast cancer (BLBC), similar to those already in routine use for detection of estrogen receptor and human epidermal growth factor receptor 2 (HER2) in… More

TAS::75 0849::TAS SBIR TOPIC 277 - DEVELOPMENT OF A CLINICAL DIAGNOSTIC ASSAY FOR ALK INHIBITOR RESISTANCE MUTATIONS

Award Year / Program / Phase:
2011 / SBIR / Phase I
Award Amount:
$193,637.00
Agency:
HHS
Principal Investigator:
David Hout – 858-549-9431
Abstract:
Kinase inhibitors have revolutionized cancer treatment but their use has led to drug resistance, prompting development of follow-on inhibitors for resistant tumors. Anaplastic lymphoma kinase (ALK) was discovered by Dr. Stephan Morris (Insight Genetics collaborator on these studies). ALK fusion… More

BIOMEDICAL (APPLIED/EXPLORATORY)

Award Year / Program / Phase:
2011 / SBIR / Phase I
Award Amount:
$149,940.00
Agency:
HHS
Principal Investigator:
Sandeep Somaiya – 703-893-6383
Abstract:
The purpose of the Phase I contract is to support Net eSolutions Corporation (NETE) in development of the software that assists in exploring multidimensional textual data, understanding complex concepts, and portfolio analysis. The tool will be useful to scientists, general public, program and… More